AIチャット

The Cooper Companies, Inc.

COO · NasdaqGS · USD

53.77 -0.84 (-1.54%)

終値時点: Sep 17, 2026, 3:59 PM

時価総額
$10.23B
出来高
5.58M

The Cooper Companies, Inc.(COO)の株価・分析・データ

本質的価値

本源的価値を読み込み中…

アナリスト予想

株価予想 →

目標株価

$58.00 – $75.00

中央値 $65.50 · 21.82% 上昇余地

12か月目標株価 · アナリスト14人

アナリストのコンセンサス: 買い

間隔:1D
ローソク足とシグナルを読み込み中…

業績

財務情報を見る →

読み込み中...

最新決算

実績予想との差前年比
売上高$1.07Bn/a+0.56%
EPS(TTM)$1.15+$0.03+4.55%

次回決算

取引時間中の予定です。

予想 · アップグレード →

決算の詳細を見る →

事業指標

買気配
49.54
純利益(TTM)
570M
0.82
2.87
18.74
11.46
PBR(TTM)
1.23
PSR(TTM)
2.41
決算発表日
Dec 10, 2026
売気配
57.44
出来高
5,584,951
平均出来高(20日)
2,748,119
始値
54.70
前日終値
54.61
当日レンジ
52.78 - 54.71
52週レンジ
51.01 - 89.83
目標株価
65.5 (21.82%)
配当
n/a
権利落ち日
Jul 26, 2023

The Cooper Companies, Inc.について

企業情報を見る →
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California. Medical Instruments & Supplies · Healthcare

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

セクター Healthcare
IPO日 Jan 21, 1983
従業員数 15,000
上場取引所 NasdaqGS
ティッカー COO
ウェブサイト https://www.coopercos.com